跨区域注册对标 / Cross-Region Benchmark
Companies and products registered in multiple regions (CDE + DMF + CEP)
Cross-Region Companies
540
CDE+DMF+CEP Triple
233
CDE+DMF Dual
445
CDE+CEP Dual
313
Cross-Region Products
1034 total, page 52 of 52| Product | CAS | CDE | DMF | CEP | Pattern | Action |
|---|---|---|---|---|---|---|
| Hydroxocobalamin Chloride 维生素B12 | 58288-50-9 | 1 | - | 1 | CDE+CEP | View → |
| Oxcarbazepine, Process II 奥卡西平 | 28721-07-5 | 1 | - | 1 | CDE+CEP | View → |
| Glimepiride, Micropowder And Super Micropowder 格列美脲 | 93479-97-1 | 1 | - | 1 | CDE+CEP | View → |
| Fluticasone Furoate, Micronised 糠酸氟替卡松 | 397864-44-7 | 1 | - | 1 | CDE+CEP | View → |
| Atorvastatin Calcium, Process II 阿托伐他汀钙 | 134523-03-8 | 1 | - | 1 | CDE+CEP | View → |
| Estradiol Valerate, Non-micronised And Micronised 雌二醇 | 979-32-8 | 1 | - | 1 | CDE+CEP | View → |
| Gabapentin, Process V 加巴喷丁 | 60142-96-3 | 1 | - | 1 | CDE+CEP | View → |
| Mirtazapine, Anhydrous 米氮平 | 85650-52-8 | 1 | - | 1 | CDE+CEP | View → |
| Teicoplanin, Changhai Site 替考拉宁 | 61036-62-2 | 1 | - | 1 | CDE+CEP | View → |
| Exemestane, Micronised (form A), Non-micronised 依西美坦 | 107868-30-4 | 1 | - | 1 | CDE+CEP | View → |
| Everolimus, Butylated Hydroxytoluene 2.0% 依维莫司 | 159351-69-6 | 1 | - | 1 | CDE+CEP | View → |
| Nevirapine Hemihydrate 奈韦拉平 | 220988-26-1 | 1 | - | 1 | CDE+CEP | View → |
| Amlodipine Besilate | 111470-99-6 | - | 1 | 1 | DMF+CEP | View → |
| Olanzapine, Form I 奥氮平 | 132539-06-1 | 1 | - | 1 | CDE+CEP | View → |